Tiziana Life Sciences looks to phase 1 trial for intranasal Alzheimer’s drug
Tiziana Life Sciences Ltd. says it plans to submit an investigational new drug (IND) application…
October 20, 2022 - 3 minutes
T-cells
Emergex develops vaccine for smallpox and monkeypox
Emergex Vaccines Holding Limited has formulated and confirmed the synthesis and assembly of a CD8+…
October 18, 2022 - 3 minutes
T-cell therapy platform trial begins in adults with blood cancers
SMART102, a human T-lymphoid progenitor cell injection derived from cord blood using Smart Immune’s ProTcell…
October 13, 2022 - 4 minutes
Estrella and TradeUP merge to become publicly traded company
Estrella Biopharma, Inc. and TradeUP Acquisition Corp. have entered into a definitive business combination agreement…
October 3, 2022 - 3 minutes
AmplifyBio acquires PACT Pharma assets
AmplifyBio has acquired select assets from PACT Pharma, Inc., a privately held biopharmaceutical company developing…
October 3, 2022 - 2 minutes
Marengo advancing its lead TCR activator into clinic after FDA clearance
Marengo Therapeutics is advancing its lead TCR activator, STAR0602, into clinic following clearance of its…
September 16, 2022 - 2 minutes
First patient with peripheral T cell lymphoma dosed with Yingli Pharma’s linperlisib
The first patient has been dosed in a phase 2 trial looking at a drug…
September 5, 2022 - 2 minutes
License agreement signed allowing drug to treat mycosis fungoides to expand in Asia, Australia and the Middle East
A license agreement has been signed between Helsinn Group and Juniper Biologics further widening the…
September 1, 2022 - 3 minutes
AIVITA Biomedical announces publication of trial results of its COVID-19 vaccine
Safety and efficacy results from phase 1 and 2 clinical trials looking at a Covid-19…
August 29, 2022 - 3 minutes
Potential new treatment for angioimmunoblastic T-cell lymphoma?
A type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations…
August 24, 2022 - 3 minutes
First patient on Innovative Cellular Therapeutics’ study looking at treating colorectal cancer
The first patient has been enrolled on a study to trial a treatment for relapsed…
August 18, 2022 - 2 minutes
Orca Bio announces Precision-T phase 3 study open and enrolling patients across US transplant centers
US-based Orca Bio, today announced Precision-T, its pivotal phase 3 study, is open, enrolling and…
August 3, 2022 - 2 minutes
